Year: 2022

Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.29 Per Common Share

Written by Customer Service on November 16, 2022. Posted in Dividend Reports And Estimates.

LOUISVILLE, Ky., Nov. 16, 2022 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per common share. The dividend will be paid on December 30, 2022, to stockholders of record as of December 19, 2022. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $7.55 billion in assets, was incorporated in 1988 as a bank holding company. It is the parent company of Stock Yards Bank & Trust Company, which was established in 1904. The Company’s common shares trade on The NASDAQ Stock Market under the symbol “SYBT.” For more information...

Immuron completes strategic investment in leading gut health biotech Ateria Health

Written by Customer Service on November 16, 2022. Posted in Mergers And Acquisitions.

Highlights:Immuron has completed settlement of strategic investment in leading gut health biotech Ateria Health, in accordance with signed subscription and option agreement (announced 13 October 2022):Strategic investment of approximately £1.5m (A$2.6m) to acquire an initial 17.5% of Ateria Health; Option for further investment of £1.47m, expiring on 31 July 2023Ateria Health is a U.K. based biotech company that develops and distributes supplements for overall health, including products that strengthen the gut microbiome. Ateria has developed and recently launched a ground-breaking product JUVIA™ for the treatment of irritable bowel syndrome (IBS) Intention to enter into reciprocal distribution agreement for Travelan® in the U.K. market and JUVIA™ in Australian and North American marketsCompletion of strategic...

Sportradar Reports Strong Growth and Increased Profitability and Cash Flow

Written by Customer Service on November 16, 2022. Posted in Earnings Releases And Operating Results.

U.S. segment revenue increased 61% year over year; achieved first-time profitability in the third quarterRest of World Betting business drove strongest organic growth with high Adjusted EBITDA marginCompany raised guidance for revenue and narrowed Adjusted EBITDA range for full year 2022 ST. GALLEN, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), the leading global technology company enabling next generation engagement in sports and provider of business-to-business solutions to the global sports betting industry, today announced financial results for its third quarter ended September 30, 2022. Third Quarter 2022 HighlightsRevenue in the third quarter of 2022 increased 31% to €178.8 million ($175.2 million)1 compared with the third quarter of 2021. 2022 year-to-date...

REE Automotive Announces Third Quarter 2022 Financial Results

Written by Customer Service on November 16, 2022. Posted in Earnings Releases And Operating Results.

Commercialization phase underway with first orders; on track and on budget for start of productionCompany Recently Received Multiple Orders for Proxima Powered by REE and P7-B Box Trucks from Some of the Largest Fleets in the US Company Expects Additional Test Fleet Orders for Proxima Powered by REE and P7-B Trucks in the Coming Months On Budget for 2H23 Start of Production with Integration Center Build Out, Design and Engineering on Time Company’s Liquidity Position Sufficient to Commercialize P7 ProgramNEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) — REE Automotive Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology leader and provider of electric vehicle (EV) platforms, today announced its financial results for the third quarter of 2022. “Over the last several months, multiple large fleets as well as delivery,...

BurgerFi Reports Third Quarter 2022 Results

Written by Customer Service on November 16, 2022. Posted in Earnings Releases And Operating Results.

Revenue Grows 290% to $43.3 million in Third Quarter First Anthony’s Multi-Unit Development Agreement Executed Conference Call Today, November 16, at 8:30 a.m. ET FORT LAUDERDALE, Fla., Nov. 16, 2022 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), today reported financial results for the third quarter ended October 3, 2022. Highlights for the Third Quarter 2022Total revenue increased to $43.3 million in the third quarter 2022 compared to $11.1 million in the prior year quarter driven by the Anthony’s acquisitionConsolidated systemwide sales increased...

Guardian Capital Announces November 2022 Distributions for Guardian Capital ETFs

Written by Customer Service on November 16, 2022. Posted in Dividend Reports And Estimates.

TORONTO, Nov. 16, 2022 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending November 30, 2022, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on November 30, 2022 to unitholders of record on November 24, 2022. The ex-dividend date in each case is November 23, 2022. Guardian Capital ETFs Series of ETF Units DistributionFrequency TSX TradingSymbol Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF Hedged ETF Units Monthly GDEP $0.0746Guardian Directed Equity Path ETF Unhedged ETF Units Monthly GDEP.B $0.0684Guardian Directed Premium Yield ETF Hedged ETF Units Monthly GDPY $0.1231Guardian Directed Premium Yield ETF Unhedged ETF Units Monthly GDPY.B $0.1133GuardPath™ Managed...

Alvotech Secures Financing Facilities of Approximately $136 Million

Written by Customer Service on November 16, 2022. Posted in Mergers And Acquisitions.

Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional investorsAlvotech acquires the Reykjavik manufacturing facility, previously utilized under a long-term lease agreement, and secures approximately $16 million, at current exchange rates, in gross loan proceeds through refinancing of secured loan facilityAlvotech secures $50 million in financing in the form of an unsecured subordinated loan facility from AlvogenREYKJAVIK, Iceland , Nov. 16, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced financing facilities securing gross proceeds of approximately $136 million, at current exchange rates. “These financing facilities are designed...

AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors

Written by Customer Service on November 16, 2022. Posted in Public Companies.

LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today the appointment of Sean McDonald to its Board of Directors which will now comprise five members. “We are pleased to welcome Sean to the board and believe his experience building and leading healthcare organizations and securing funding for early-stage companies will be invaluable to our mission at AccuStem,” said Wendy Blosser, Chief Executive Officer and board member of AccuStem. Sean joins the AccuStem board while serving as the CEO of Ocugenix, a therapeutics company focused on the development and commercialization of therapies for ocular diseases caused by excessive fibrosis and blood vessels in the eye. Sean served as a director...

Aravive Regains Compliance with Nasdaq Minimum Bid Price Requirement

Written by Customer Service on November 16, 2022. Posted in Public Companies.

HOUSTON, Nov. 16, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the receipt of a formal notification from the Staff at The Nasdaq Stock Market, LLC (“Nasdaq”) on November 10, 2022 that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Company was previously notified by the Staff at Nasdaq on August 9, 2022 that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules. Since then, the Staff at Nasdaq has determined that for 11 consecutive business days, from October 27, 2022 to November 10, 2022, the closing bid price of the Company’s...

Eagle Pharmaceuticals’ Investor Day to Feature World-Renowned KOLs on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel

Written by Customer Service on November 16, 2022. Posted in Public Companies.

— Featured speakers and KOLs include: Scott Tarriff, Herm Cukier, Dr. Richard Dutton, Dr. Prem Fort, Dr. TJ Gan, Dr. Andre Kalil, Dr. Joseph Pergolizzi and Dr. Eugene Vortsman — — Topics include the clinical and scientific rationale for the Company’s hospital-based products and pipeline programs: Enalare’s ENA-001, CAL02, BARHEMSYS®, BYFAVO® and landiolol — WOODCLIFF LAKE, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the following speakers and world-renowned Key Opinion Leaders will be featured at the Company’s Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel, at 8:00am ET:Scott Tarriff, President and Chief Executive Officer of Eagle Pharmaceuticals, and senior members of the Company’s clinical...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals